ADIA Nutrition Inc Partners with Former WWE Wrestler to Expand Portfolio

Winter Park, Florida–(Newsfile Corp. – July 30, 2024) – ADIA Nutrition (OTC Pink: ADIA), an innovative player in the nutrition and supplement industry, is thrilled to announce its strategic partnership with Cement Factory Nutrition, a dynamic health and wellness company. This collaboration marks a significant step for ADIA Nutrition as it continues to diversify and enhance its product offerings and portfolio.

Jeff Sciullo, formerly known as Elias from WWE and part owner of Cement Factory Nutrition, expressed his excitement about the partnership: “We are proud to join forces with ADIA Nutrition. Our team at Cement Factory Nutrition is committed to delivering innovative products that cater to the unique needs of our customers. By partnering with ADIA, we can leverage their expertise and resources to create exceptional nutritional solutions.”

Jeff Sciullo, formerly known as Elias from WWE

To view an enhanced version of this graphic, please visit:
https://images.newsfilecorp.com/files/10520/218111_jeff_scuilo.jpg

Sciullo’s partners and founders at Cement Factory Nutrition include:

AJ Sims: A professional bodybuilder and coach, Sims brings a wealth of experience to the table. His dedication to health and fitness aligns perfectly with our vision.

Tomislav Marjanovic: CEO and co-founder of Cement Factory Nutrition and owner of Aspire Rejuvenation Clinic. Marjanovic understands the importance of holistic wellness. His expertise will contribute significantly to our joint efforts.

ADIA Nutrition’s investment in this partnership will be in the form of Series C Preferred Shares. Larry Powalisz, CEO of ADIA Nutrition, expressed his satisfaction with the arrangement: “We appreciate Jeff Sciullo and his partners’ faith in ADIA Nutrition. Their decision to receive shares of our company rather than cash demonstrates their confidence in our growth potential. We look forward to a successful collaboration.”

About ADIA Nutrition Inc.:
Adia Nutrition Inc. is a publicly traded company (OTC Pink: ADIA) dedicated to revolutionizing healthcare and supplementation. With a focus on innovation and quality, the company has established two key divisions: a supplement division providing premium, organic supplements, and a medical division specializing in Autologous Hematopoietic Stem Cell Transplantation (aHSCT) treatments for Multiple Sclerosis (MS). Through these divisions, Adia Nutrition Inc. is committed to empowering individuals to live their best lives by addressing both nutritional needs and groundbreaking medical treatments.

Website: www.adianutrition.com
Website: adia-med.com
Website: biolete.com
Website: cementfactory.com

Twitter (X): @ADIA_Nutrition

Safe Harbor: This Press Release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. These forward-looking statements are based on the current plans and expectations of management and are subject to a few uncertainties and risks that could significantly affect the company’s current plans and expectations, as well as future results of operations and financial condition. A more extensive listing of risks and factors that may affect the company’s business prospects and cause actual results to differ materially from those described in the forward-looking statements can be found in the reports and other documents filed by the company with the Securities and Exchange Commission and OTC Markets, Inc. OTC Disclosure and News Service. The company undertakes no obligation to publicly update or revise any forward-looking statements, because of new information, future events or otherwise.

AJ Sims

To view an enhanced version of this graphic, please visit:
https://images.newsfilecorp.com/files/10520/218111_aj_sims.jpg

adia-med.com

To view an enhanced version of this graphic, please visit:
https://healthtechnologynet.com/wp-content/uploads/2024/07/218111_cement_factory.jpg

To view the source version of this press release, please visit https://www.newsfilecorp.com/release/218111